Skip to content

The Effects of Physiotherapy in Migraine

The Effects of Physiotherapy Applications in Individuals With Migraine

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07657377
Enrollment
50
Registered
2026-06-18
Start date
2026-08-01
Completion date
2027-08-01
Last updated
2026-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Migraine

Brief summary

The aim of this study is to investigate the effects of a physiotherapy program including cervical muscle training and transcutaneous vagus nerve stimulation on pain, functional status, quality of life, psychological status, and sleep quality in individuals with migraine.

Interventions

A physiotherapy program including taVSS and cervical muscle exercises

Sponsors

Ankara Yildirim Beyazıt University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

* Volunteering to participate in the study * Being between 18 and 55 years of age * Being diagnosed with migraine by a neurologist according to the International Classification of Headache Disorders 3 (ICHD-3) criteria

Exclusion criteria

* Diagnosis of other primary and/or secondary headaches in addition to migraine, * Coexisting neurological and/or rheumatological diseases, * Severe psychiatric disorders (bipolar disorder, schizophrenia, psychosis, etc.), * Pregnancy or lactation, * Malignancy, * Known arrhythmia or presence of any implanted electronic device, * Presence of sensory loss in the application area, * Having received physiotherapy or any other treatment in the head/neck region within the last 12 months, * History of head/neck trauma or surgery within the last 12 months.

Design outcomes

Primary

MeasureTime frameDescription
Pain AssessmentBaseline, 8th week (after treatment)Individuals' pain parameters will be assessed using a pain diary.

Secondary

MeasureTime frameDescription
Assessment of Functional StatusBaseline, 8th week (after treatment)The Migraine Disability Assessment Scale will be used to determine the functional status associated with migraine. This scale aims to evaluate headache-related disability and the functionality of individuals diagnosed with migraine in daily and social activities.
Quality of Life AssessmentBaseline, 8th week (after treatment)The Migraine-Specific Quality of Life Scale (Version 2.1) will be used to assess quality of life.
Assessment of Psychological StateBaseline, 8th week (after treatment)The Hospital Anxiety and Depression Scale will be used to assess psychological status.
Sleep Quality AssessmentBaseline, 8th week (after treatment)The Single-Item Sleep Quality Scale will be used to assess sleep quality.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 19, 2026